Overview
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 31, 2026 | Congruence Therapeutics: $39.5 Million Secured To Advance Small Molecule Correctors Into Clinical Development | Congruence Therapeutics has announced the closing of a $39.5 million financing to support the advancement of its pipeline of small molecule correctors targeting diseases caused by protein misfolding. The financing round was co-led by Dimens... |
| Mar 16, 2026 | Alto Neuroscience: $120 Million Raised To Advance Treatment-Resistant Depression Drug Candidate | Alto Neuroscience, a clinical-stage biopharmaceutical company developing precision medicines for neuropsychiatric disorders, announced it has secured approximately $120 million in a private placement financing. The financing was led by Comm... |
| Sep 12, 2025 | Congruence Therapeutics: $32 Million Financing Raised For Advancing Genetic Obesity Therapy | Congruence Therapeutics has secured a $32 million financing round to support the development of its lead candidate CGX-926, the first clinical therapy designed to treat MC4R-deficient genetic obesity. The proceeds will fund a Phase 1 trial ... |
| Oct 30, 2024 | GlycoMimetics To Acquire Crescent Biopharma | GlycoMimetics (NASDAQ: GLYC), a Rockville, MD-based late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, acquired Crescent Biopharma, Inc., a biotechnology company advancing a pipeli... |
| Oct 24, 2024 | Jade Biosciences Extends Financing; Total To $95M | Jade Biosciences, a Vancouver, BC, Canada-based biotechnology company dedicated to developing therapies for patients living with autoimmune diseases, extended its financing, bringing the total raised to $95M. The round added Frazier Life Sc... |
| Aug 4, 2024 | INQ Holdings, SBI funds, Citigroup biggest buyers in Adani Energy's $1 billion QIP | A unit of Qatar Investment Authority, SBI Mutual Fund, and foreign investment funds Nomura and Citigroup were the biggest buyers of shares in Adani group's power transmission unit's $1 billion QIP, according to a stock exchange filing by th... |
| Apr 15, 2021 | C2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence Platform | – Cancer intelligence company, C2i Genomics announced it has raised $100M in financing from Casdin Capital, NFX, Duquesne Family Office, Section 32, iGlobe Partners, Driehaus Capital and others. – Funds will be used to accelerate clinical d... |
| Feb 18, 2009 | Airband books $3M for its fixed-wireless network | Airband, the Dallas-based provider of a fixed-wireless network for businesses, announced that it brought in $3 million in sixth-round funding from undisclosed investors to continue building out its existing network. The nine-year-old compan... |
Reviews 0
FAQ about Driehaus Capital Management
When was Driehaus Capital Management founded?
Driehaus Capital Management was founded in 1982.
What has the press written about Driehaus Capital Management?
Parsers VC has collected 9 articles mentioning Driehaus Capital Management, among them “Congruence Therapeutics: $39.5 Million Secured To Advance Small Molecule Correctors Into Clinical Development” (Mar 31, 2026) and “Alto Neuroscience: $120 Million Raised To Advance Treatment-Resistant Depression Drug Candidate” (Mar 16, 2026).
Is Driehaus Capital Management still active?
Yes, Driehaus Capital Management is active; its latest activity on Parsers VC dates from Jun 15, 2026.